Christopher R. Fenimore, VP Controller at REGENERON PHARMACEUTICALS, INC. (REGN), sold 4,731 shares at $376.27 ($1.8M) on 2019-12-13, disclosed to the SEC on 2019-12-13.
Open-market sale of $1.8M REGN by VP Controller. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $377.16 | 1,418 | $535K | 30.0% |
| 2 | $374.82 | 191 | $72K | 4.0% |
| 3 | $374.82 | 191 | $72K | 4.0% |
| 4 | $375.58 | 624 | $234K | 13.2% |
| 5 | $375.58 | 624 | $234K | 13.2% |
| 6 | $376.27 | 470 |
| $177K |
| 9.9% |
| 7 | $376.27 | 470 | $177K | 9.9% |
| 8 | $377.38 | 346 | $131K | 7.3% |
| 9 | $377.38 | 346 | $131K | 7.3% |
| 10 | $378.27 | 51 | $19K | 1.1% |
| Total | $376.42 avg | 4,731 | $1.8M | 100% |
| Filing → |
| REGN | SELL | 2023-12-29 | $4.2M | — | Filing → |
| REGN | SELL | 2023-12-26 | $3.3M | — | Filing → |
| REGN | SELL | 2023-03-27 | $3.5M | — | Filing → |